The following sympathomimetic amine has agonistic action on a1 + a2 + b1 + b3 adrenoceptors, but not on b2 receptors
**Core Concept**
The question tests the student's knowledge of sympathomimetic amines, specifically their agonistic action on adrenergic receptors. The correct answer is a drug that selectively activates alpha-1 (α1), alpha-2 (α2), beta-1 (β1), and beta-3 (β3) adrenergic receptors, but not beta-2 (β2) receptors.
**Why the Correct Answer is Right**
The correct answer is a non-selective adrenergic agonist, meaning it can activate multiple subtypes of adrenergic receptors. This is in contrast to selective agonists, which target a specific receptor subtype. The activation of α1, α2, β1, and β3 receptors can lead to various physiological effects, such as vasoconstriction, decreased sympathetic tone, increased heart rate, and lipolysis. The lack of activation on β2 receptors is important, as this subtype is primarily responsible for bronchodilation and vasodilation in skeletal muscle.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is likely a selective β1 agonist, such as isoproterenol, which activates β1 receptors but not α1, α2, or β3 receptors. This would not match the given pharmacological profile.
* **Option B:** This option is likely a selective α1 agonist, such as phenylephrine, which activates α1 receptors but not α2, β1, or β3 receptors. This would not match the given pharmacological profile.
* **Option C:** This option is likely a selective β2 agonist, such as albuterol, which activates β2 receptors but not α1, α2, or β3 receptors. This would not match the given pharmacological profile.
* **Option D:** This option is likely a selective α2 agonist, such as clonidine, which activates α2 receptors but not α1, β1, or β3 receptors. This would not match the given pharmacological profile.
**Clinical Pearl / High-Yield Fact**
When selecting a sympathomimetic amine, it's essential to consider the specific adrenergic receptors that need to be activated or blocked. This is crucial in managing conditions such as hypertension, heart failure, and asthma.
**Correct Answer:**
Please note that the correct option is missing from the original question.